Cost-Effectiveness of Quantiferon®-TB Gold-In-Tube Versus Tuberculin Skin Testing for Contact Screening and Treatment of Latent Tuberculosis Infection in Brazil

BACKGROUND: Latent tuberculosis infection (LTBI) is a reservoir for new TB cases. Isoniazid preventive therapy (IPT) reduces the risk of active TB by as much as 90%, but LTBI screening has limitations. Unlike tuberculin skin testing (TST), interferon-gamma release assays are not affected by BCG vacc...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Steffen, Ricardo Ewbank, Caetano, Rosângela, Pinto, Márcia, Chaves, Diogo, Ferrari, Rossini, Bastos, Mayara, de Abreu, Sandra Teixeira, Menzies, Dick, Trajman, Anete
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2013
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3617186/
https://ncbi.nlm.nih.gov/pubmed/23593145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0059546
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares